| Literature DB >> 29386016 |
Saima Ali1, Muhammad Rashid Khan2, Moniba Sajid1, Zartash Zahra1.
Abstract
BACKGROUND: Parrotiopsis jacquemontiana (Decne) Rehder. is locally used for skin infections and in wound healing. In this study we have evaluated methanol extract of its leaves and derived fractions against the clinical multi-drug resistant bacterial strains.Entities:
Keywords: Bacterial strains; Fungal strains; Minimum inhibitory concentration; Multi drug resistance; Parrotiopsis jacquemontiana
Mesh:
Substances:
Year: 2018 PMID: 29386016 PMCID: PMC5793404 DOI: 10.1186/s12906-018-2114-z
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Extraction yield of P. jacquemontiana methanol extract and its corresponding fractions
| Plant sample | Percentage yield (%) |
|---|---|
| PJM | 50a |
| PJH | 30 |
| PJC | 2 |
| PJE | 36 |
| PJB | 12 |
| PJA | 18 |
PJM (P. jacquemontiana methanol fraction), PJH (P. jacquemontiana n-hexane fraction), PJC (P. jacquemontiana chloroform fraction), PJE (P. jacquemontiana ethyl acetate fraction), PJB (P. jacquemontiana butanol fraction), PJA (P. jacquemontiana aqueous fraction)
aYield of PJM in grams based on dry powder weight; fraction yield dependent upon PJM yield
Qualitative phytochemical analysis of P. jacquemontiana leaves methanol extract and its derived fractions
| Phytochemical | PJM | PJH | PJC | PJE | PJB | PJA |
|---|---|---|---|---|---|---|
| Terpenoids | + | + | + | – | – | – |
| Triterpenoids | + | + | + | – | – | – |
| Coumarins | + | – | + | + | + | + |
| Flavonoids | ||||||
| Alkaline reagent test | + | – | + | – | + | + |
| FeCl3 test | + | – | + | – | + | + |
| Tannins | ||||||
| Alkaline reagent test | + | – | + | + | + | + |
| FeCl3 test | + | – | + | + | + | + |
| Condensed Tannins | + | – | – | + | + | + |
| Hydrolysable tannins | – | + | + | – | – | – |
| Phlobatannins | + | – | – | + | + | – |
| Steroids | + | – | – | + | + | + |
| Phytosteroids | – | – | – | + | + | + |
| Anthraquinones | – | – | – | – | – | – |
| Phenols | + | – | + | – | – | – |
| Alkaloids | ||||||
| Mayer’s test | + | + | + | + | + | – |
| Hager’s test | + | + | + | + | + | – |
| Glycosides | + | + | + | + | + | + |
| Saponins | + | – | – | + | + | – |
| Sterols | + | – | – | + | – | + |
| Quinones | + | + | + | + | + | + |
| Acids | + | + | + | + | + | + |
| Vitamin C | + | + | + | + | + | + |
| Proteins | ||||||
| Xanthoproteic test | + | + | + | + | + | + |
| Biuret test | + | + | + | + | + | + |
| Carbohydrates | – | – | – | + | + | – |
| Oils and Resins | + | + | + | + | + | + |
| Anthocyanin | – | – | – | – | – | – |
| Betacyanin | + | – | + | – | + | + |
PJM methanol extract of P. jacquemontiana leaves, PJH n-hexane fraction of PJM, PJC chloroform fraction of PJM; PJE ethyl acetate fraction of PJM, PJB n-butanol fraction of PJM, PJA residual aqueous fraction of PJM. (+) constituent present, (−) constituent absent
Quantitative phytochemical analysis of P. jacquemontiana leaves methanol extract and its derived fractions
| Percentage (%) yield per gram | mg of GAE/ g of extract | ||||
|---|---|---|---|---|---|
| Plant extracts | Alkaloids | Flavonoids | Saponins | Phenols | Tannins |
| PJM | 12.5 ± 0.17 | 7.4 ± 0.14 | 4.4 ± 0.42 | 611.5 ± 2.18 | 159.4 ± 1.85 |
| PJH | 0.71 ± 0.21 | NT | NT | NT | NT |
| PJC | 7.7 ± 0.14 | 3.5 ± 0.07 | NT | 342.8 ± 1.69 | 203.8 ± 2.67 |
| PJE | 22.5 ± 0.5 | NT | 5.5 ± 0.28 | NT | 244.3 ± 2.03 |
| PJB | 5.7 ± 0.36 | 6.6 ± 0.42 | 1.8 ± 0.11 | NT | 231.6 ± 1.93 |
| PJA | NT | 4.6 ± 0.11 | NT | NT | 110.5 ± 0.74 |
Mean ± SD (n = 3), PJM P. jacquemontiana methanol fraction, PJH P. jacquemontiana n-hexane fraction, PJC P. jacquemontiana chloroform fraction, PJE P. jacquemontiana ethyl acetate fraction, PJB P. jacquemontiana butanol fraction, PJA P. jacquemontiana aqueous fraction, NT Not Tested
Antibacterial screening of P. jacquemontiana extract against gram positive and gram negative bacteria
| Extract/Fractions (1000 μg/disc) | ||||||
|---|---|---|---|---|---|---|
| Isolate (s) | PJM | PJH | PJC | PJE | PJB | PJA |
| Staphylococcus aureus | ||||||
| MDR (6301) | 24.16 ± 1.25 | 27.66 ± 0.28 | 25.16 ± 1.04 | 28 ± 1.32 | 24.16 ± 1.04 | – |
| MDR (3884) | 31.16 ± 2.02 | 29 ± 1.0 | 24.83 ± 0.28 | 26.5 ± 0.5 | 28.66 ± 0.28 | – |
| MRSA (12861) | 22.5 ± 1.32 | 23.16 ± 1.25 | 25 ± 0.5 | 26 ± 1.0 | 25.33 ± 1.04 | – |
| MDR (9861) | 25.16 ± 0.04 | 22.5 ± 0.5 | 26.33 ± 1.25 | 26.5 ± 0.86 | 28.83 ± 0.76 | – |
| (5764) | 29 ± 1.0 | 26 ± 1.0 | 27.33 ± 0.57 | 27 ± 1,0 | 23.5 ± 0.5 | – |
| (31414) | 26 ± 1.0 | 32 ± 0.86 | 30.33 ± 1.44 | 22.5 ± 0.5 | 25 ± 1.0 | – |
| Staphylococcus lugdenesis | ||||||
| MDR (6197) | 35.5 ± 1.32 | 28.5 ± 0.5 | 24.83 ± 1.04 | 26.5 ± 0.5 | 26.83 ± 0.28 | – |
| (4338) | 24 ± 1.0 | 18 ± 1.0 | - | 25.66 ± .57 | 20.5 ± 0.86 | – |
| Escherichia coli | ||||||
| MDR (52331) | 27.83 ± 0.76 | 28.83 ± 0.28 | 24.83 ± 1.25 | 24.33 ± 0.57 | 31.16 ± 0.76 | – |
| (22244) | 28 ± 0.5 | 13.16 ± 0.28 | 14 ± 1.0 | 27.83 ± 0.76 | 23.5 ± 0.86 | – |
| | 23.5 ± 0.5 | - | - | 24.16 ± 0.76 | 18.33 ± 1.04 | – |
| | 24.5 ± 0.5 | - | - | 25.66 ± 0.28 | 19 ± 1.0 | – |
| Klebsiella pneumoniae | ||||||
| MDR (82431) | 30 ± 1.0 | 26 ± 2.0 | 26.66 ± 0.28 | 25.16 ± 0.28 | 33.33 ± 0.57 | – |
| | 35.33 ± 0.57 | 34 ± 1.0 | 29.5 ± 0.5 | 26 ± 1.0 | 28.16 ± 0.76 | – |
| (34529) | 27.83 ± 0.28 | 17.16 ± 1.04 | 18 ± 1.0 | 21.83 ± 1.04 | 20 ± 1.0 | – |
| (35967) | 22.16 ± 0.76 | - | - | 20.83 ± 1.04 | 19 ± 0.86 | – |
| | 26 ± 2.0 | - | - | 23.83 ± 0.57 | 19 ± 0.5 | – |
| Pseudomonas aeruginosa | ||||||
| (27853) | 25.16 ± 0.76 | 21.5 ± 0.5 | 14 ± 2.0 | 19.66 ± 1.52 | 18.33 ± 0.57 | – |
| Coagulase negative staphylococci | ||||||
| (12731) | 28 ± 2.0 | 27.33 ± 0.57 | 22 ± 1.0 | 25.16 ± 1.04 | 26.16 ± 0.76 | – |
Zone of inhibition (mm) are expressed as mean ± SD (n = 3). 8-13 mm: low inhibition; 14-19 mm: moderate inhibition; ≥ 20 mm: high inhibition. -: no zone of inhibition; NT not tested, PJM methanol extract of P. jacquemontiana leaves, PJH: n-hexane fraction of PJM, PJC chloroform fraction of PJM, PJE ethyl acetate fraction of PJM, PJB n-butanol fraction of PJM, PJA residual aqueous fraction of PJM
MIC and MBC of P. jacquemontiana extracts against gram positive and gram negative bacteria
| Extract/Fractions (μg /ml) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PJM | PJH | PJC | |||||||
| Isolate(s) | MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC |
| Staphylococcus aureus | |||||||||
| MDR (6301) | 32 | 64 | 02 | 64 | 256 | 04 | 128 | 512 | 04 |
| MDR (3884) | 16 | 64 | 04 | 128 | 256 | 02 | 128 | 256 | 02 |
| MRSA (12861) | 08 | 32 | 04 | 16 | 128 | 08 | 32 | 128 | 04 |
| MDR (9861) | 32 | 64 | 02 | 32 | 128 | 04 | 128 | 256 | 02 |
| (5764) | 16 | 128 | 08 | 128 | 256 | 02 | 64 | 256 | 04 |
| (31414) | 08 | 32 | 04 | 16 | 128 | 08 | 32 | 256 | 08 |
| Staphylococcus lugdenesis | |||||||||
| MDR (6197) | 32 | 128 | 04 | 64 | 128 | 02 | 512 | 512 | 01 |
| (4338) | 16 | 64 | 04 | 64 | 256 | 04 | – | – | – |
| Escherichia coli | |||||||||
| MDR (52331) | 32 | 128 | 04 | 64 | 128 | 02 | 256 | 512 | 02 |
| (22244) | 08 | 64 | 08 | 32 | 64 | 02 | 64 | 256 | 04 |
| | 08 | 32 | 04 | – | – | – | – | – | – |
| | 08 | 32 | 04 | – | – | – | – | – | – |
| Klebsiella pneumoniae | |||||||||
| MDR (82431) | 64 | 256 | 04 | 128 | 512 | 04 | 128 | 512 | 04 |
| | 16 | 64 | 04 | 64 | 256 | 04 | 256 | 512 | 02 |
| (34529) | 08 | 32 | 04 | 08 | 64 | 08 | 32 | 128 | 04 |
| (35967) | 08 | 32 | 04 | – | – | – | – | – | – |
| | 08 | 64 | 08 | – | – | – | – | – | – |
| Pseudomonas aeruginosa | |||||||||
| (27853) | 08 | 64 | 08 | 32 | 128 | 04 | 128 | 256 | 02 |
| Coagulase negative staphylococci | |||||||||
| (12731) | 64 | 128 | 02 | 64 | 256 | 04 | 128 | 512 | 04 |
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, PJM methanol extract of P. jacquemontiana leaves, PJH n-hexane fraction of PJM, PJC chloroform fraction of PJM; −: no zone of inhibition
MIC and MBC of P. jacquemontiana extracts and cefixime against gram positive and gram negative bacteria
| Extract/Fractions (μg/ml) | Antibiotic used (μg/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| PJE | PJB | Cefixime | |||||||
| Clinical Isolate(s) | MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC | MIC | MBC | MBC/MIC |
| Staphylococcus aureus | |||||||||
| MDR (6301) | 32 | 64 | 02 | 128 | 256 | 02 | 16 | 64 | 04 |
| MDR (3884) | 08 | 32 | 04 | 64 | 256 | 04 | 08 | 16 | 02 |
| MRSA (12861) | 08 | 64 | 08 | 32 | 128 | 04 | 64 | 64 | 01 |
| MDR (9861) | 32 | 128 | 04 | 64 | 128 | 02 | 64 | 128 | 02 |
| (5764) | 32 | 128 | 04 | 64 | 256 | 04 | 32 | 64 | 02 |
| (31414) | 16 | 64 | 04 | 08 | 64 | 08 | 08 | 16 | 02 |
| Staphylococcus lugdenesis | |||||||||
| MDR (6197) | 32 | 128 | 04 | 512 | 512 | 01 | 32 | 32 | 01 |
| (4338) | 16 | 64 | 04 | 32 | 128 | 04 | 08 | 32 | 04 |
| Escherichia coli | |||||||||
| MDR (52331) | 64 | 128 | 02 | 128 | 128 | 01 | 128 | 128 | 01 |
| (22244) | 08 | 32 | 04 | 16 | 64 | 04 | 16 | 32 | 02 |
| | 08 | 64 | 08 | 32 | 128 | 04 | 16 | 32 | 02 |
| | 08 | 64 | 08 | 32 | 128 | 04 | 08 | 32 | 04 |
| Klebsiella pneumoniae | |||||||||
| MDR (82431) | 32 | 256 | 08 | 32 | 128 | 04 | 128 | 128 | 01 |
| | 16 | 64 | 04 | 32 | 256 | 08 | 64 | 128 | 02 |
| (34529) | 08 | 32 | 04 | 08 | 64 | 08 | 08 | 16 | 02 |
| (35967) | 08 | 64 | 08 | 16 | 128 | 08 | 64 | 128 | 02 |
| | 08 | 64 | 08 | 16 | 64 | 04 | 02 | 08 | 04 |
| Pseudomonas aeruginosa | |||||||||
| (27853) | 16 | 64 | 04 | 08 | 128 | 16 | 08 | 64 | 08 |
| Coagulase negative staphylococci | |||||||||
| (12731) | 32 | 128 | 04 | 32 | 128 | 04 | 64 | 128 | 02 |
MIC minimum inhibitory concentration, MBC minimum bactericidal concentration, PJE ethyl acetate fraction of PJM, PJB n-butanol fraction of PJM, PJA residual aqueous fraction of PJM
Antifungal screening of P. jacquemontiana extract/fractions
| Extract/fractions (1000 μg/disc) | ||||||
|---|---|---|---|---|---|---|
| Fungal isolates | PJM | PJH | PJC | PJE | PJB | PJA |
| 20.33 ± 1.25 | – | – | 24.83 ± 1.04 | 17.33 ± 1.52 | – | |
| 22.66 ± 2.08 | – | – | 21.33 ± 1.52 | 23.66 ± .57 | – | |
| 29 ± 1.0 | – | – | 23.33 ± 1.25 | 15.16 ± 1.04 | – | |
| 26.66 ± 0.57 | – | – | 18.66 ± 0.28 | 24 ± 2.0 | – | |
| 23.33 ± 1.25 | – | – | 25.5 ± 0.5 | 25.83 ± 0.28 | – | |
|
| 25 ± 1.0 | – | – | 26.83 ± 0.76 | 21.66 ± 0.28 | – |
| 27.33 ± 0.76 | – | – | 25.16 ± 1.60 | 22.5 ± 1.32 | – | |
| 25.33 ± 1.52 | – | – | 28 ± 1.0 | 19.83 ± 1.25 | – | |
Zone of inhibition (mm) are expressed as mean ± SD (n = 3). 8-13 mm: low inhibition; 14-19 mm: moderate inhibition; ≥20 mm: high inhibition. -: no zone of inhibition. PJM methanol extract of P. jacquemontiana leaves, PJH n-hexane fraction of PJM, PJC chloroform fraction of PJM, PJE ethyl acetate fraction of PJM, PJB n-butanol fraction of PJM, PJA residual aqueous fraction of PJM
Antifungal screening of P. jacquemontiana extracts and clotrimazole
| Extract/Fractions (μg/ml) | Standard (μg/ml) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PJM | PJE | PJB | Clotrimazole | |||||||||
| Clinical Isolate(s) | MIC | MFC | MFC/MIC | MIC | MFC | MFC/MIC | MIC | MFC | MFC/MIC | MIC | MFC | MFC/MIC |
| 32 | 128 | 04 | 32 | 64 | 02 | 32 | 128 | 04 | 04 | 08 | 02 | |
| 16 | 32 | 02 | 16 | 128 | 08 | 128 | 256 | 02 | 32 | 64 | 02 | |
| 08 | 32 | 04 | 32 | 256 | 08 | 128 | 512 | 04 | 32 | 128 | 04 | |
| 32 | 128 | 04 | 08 | 128 | 16 | 32 | 64 | 02 | 08 | 16 | 02 | |
| 64 | 256 | 04 | 64 | 256 | 04 | 64 | 128 | 02 | 16 | 64 | 04 | |
|
| 64 | 256 | 04 | 64 | 512 | 08 | 32 | 512 | 16 | 64 | 128 | 02 |
| 08 | 64 | 08 | 32 | 64 | 02 | 32 | 256 | 08 | 08 | 32 | 04 | |
| 16 | 32 | 02 | 08 | 32 | 04 | 64 | 512 | 08 | 16 | 64 | 04 | |
MIC minimum inhibitory concentration, MFC minimum fungicidal concentration, PJM methanol extract of P. jacquemontiana leaves, PJE ethyl acetate fraction of PJM, PJB n-butanol fraction of PJM, PJA residual aqueous fraction of PJM